Generally, drug development is a long process because a potential new drug must be identified and then evaluated in preclinical and clinical studies.
Although there are different regulatory paths for different types of products, most oncology drugs follow a similar overarching drug development path. The traditional drug development pathway can take up to approximately 15 years, but efforts have been made by industry and the FDA to reduce this timeline.
Much more about this process here: cancertherapyadvisor.com/ho...
Jackie